MyFinsight
Home
Blog
About
Marketable investment
securities
$18,287,179
(53.78%↑ Y/Y)
Cash and cash
equivalents
$4,979,430
(-17.61%↓ Y/Y)
License fee and
royalties receivable
$190,099
Prepaid and other
current assets
$179,004
(-50.64%↓ Y/Y)
Accrued interest income
$101,065
(-16.98%↓ Y/Y)
Total current assets
$23,736,777
(28.86%↑ Y/Y)
Property and equipment,
net of accumulated...
$74,831
(-43.90%↓ Y/Y)
Other assets
$23,753
(0.00%↑ Y/Y)
Total assets
$23,835,361
(28.30%↑ Y/Y)
Total liabilities and
stockholders equity
$23,835,361
(28.30%↑ Y/Y)
Total stockholders
equity
$21,767,404
(27.08%↑ Y/Y)
Total liabilities
$2,067,957
(42.74%↑ Y/Y)
Accumulated deficit
-$215,690,856
(-5.81%↓ Y/Y)
Treasury stock at cost,
336 shares
$40,712
(0.00%↑ Y/Y)
Accumulated other
comprehensive income
-$13,401
(-978.12%↓ Y/Y)
Additional paid-in capital
$237,503,220
(7.47%↑ Y/Y)
Total current
liabilities
$2,067,957
(42.74%↑ Y/Y)
Common stock, par value
0.0001 per share,...
$9,153
(3.25%↑ Y/Y)
Accrued expenses
$1,067,432
(55.65%↑ Y/Y)
Accounts payable
$680,525
(53.62%↑ Y/Y)
Deferred revenue
$320,000
(0.00%↑ Y/Y)
Back
Back
Balance Sheet
Lipocine Inc. (LPCN)
Lipocine Inc. (LPCN)
source: myfinsight.com